AQP4 and Ataxia: In more than half of our patients with NMDARE-associated ataxia, we were able to exclude the presence of MOG, AQP-4, KLHL11, and GluK2 antibodies, all of which have previously been associated with both NMDAR-E and CNS neurological deficits including ataxia (14–18).